Yubo International Biotech annual shares outstanding
2012
2013
2014
2015
2016
2017
2018
2019
2020
2020
2021
2022
2023
2024
2025
Yubo International Biotech Shares Outstanding History (YBGJ)
Yubo International Biotech reported 170.4M shares outstanding at the end of fiscal 2025.
View full Yubo International Biotech company overviewYubo International Biotech annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 170.4M | 50.6M | +42.23% |
| 2024 | 2024-12-31 | 119.8M | 0 | 0.00% |
| 2023 | 2023-12-31 | 119.8M | 0 | 0.00% |
| 2022 | 2022-12-31 | 119.8M | 1.6M | +1.39% |
| 2021 | 2021-12-31 | 118.2M | 0 | 0.00% |
| 2020 · Dec 31 | 2020-12-31 | 118.2M | — | — |
| 2020 · Feb 29 | 2020-02-29 | 1.2M | 0 | 0.00% |
| 2019 | 2019-02-28 | 1.2M | 0 | 0.00% |
| 2018 | 2018-02-28 | 1.2M | 0 | 0.00% |
| 2017 | 2017-02-28 | 1.2M | 2,389 | +0.20% |
| 2016 | 2016-02-29 | 1.2M | 0 | 0.00% |
| 2015 | 2015-02-28 | 1.2M | −2,956 | −0.25% |
| 2014 | 2014-02-28 | 1.2M | 0 | 0.00% |
| 2013 | 2013-02-28 | 1.2M | 3,304 | +0.28% |
| 2012 | 2012-02-29 | 1.2M | — | — |
Yubo International Biotech quarterly shares outstanding
Q4.11
Q4.12
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 170.4M | 4,447 | +0.00% |
| Q1 2026 | 2026-03-31 | 170.4M | 50.6M | +42.24% |
| Q4 2025 | 2025-12-31 | 170.4M | 50.6M | +42.23% |
| Q3 2025 | 2025-09-30 | 170.4M | 50.6M | +42.23% |
| Q2 2025 | 2025-06-30 | 170.4M | 50.6M | +42.23% |
| Q1 2025 | 2025-03-31 | 119.8M | 0 | 0.00% |
| Q4 2024 | 2024-12-31 | 119.8M | 0 | 0.00% |
| Q3 2024 | 2024-09-30 | 119.8M | 0 | 0.00% |
| Q2 2024 | 2024-06-30 | 119.8M | 0 | 0.00% |
| Q1 2024 | 2024-03-31 | 119.8M | 0 | 0.00% |
| Q4 2023 | 2023-12-31 | 119.8M | 0 | 0.00% |
| Q3 2023 | 2023-09-30 | 119.8M | 0 | 0.00% |
| Q2 2023 | 2023-06-30 | 119.8M | 1.6M | +1.39% |
| Q1 2023 | 2023-03-31 | 119.8M | 1.6M | +1.39% |
| Q4 2022 | 2022-12-31 | 119.8M | 1.6M | +1.39% |
| Q3 2022 | 2022-09-30 | 119.8M | 1.6M | +1.39% |
| Q2 2022 | 2022-06-30 | 118.2M | 0 | 0.00% |
| Q1 2022 | 2022-03-31 | 118.2M | 0 | 0.00% |
| Q4 2021 | 2021-12-31 | 118.2M | 0 | 0.00% |
| Q3 2021 · Sep 30 | 2021-09-30 | 118.2M | — | — |
| Q2 2021 · Jun 30 | 2021-06-30 | 118.2M | 117.0M | +9925.59% |
| Q1 2021 · Mar 31 | 2021-03-31 | 118.2M | — | — |
| Q4 2020 · Dec 31 | 2020-12-31 | 118.2M | — | — |
| Q3 2021 · Nov 30 | 2020-11-30 | 118.2M | 117.0M | +9925.59% |
| Q2 2021 · Aug 31 | 2020-08-31 | 117.9M | 116.7M | +9900.05% |
| Q1 2021 · Jul 2 | 2020-07-02 | 1.2M | — | — |
| Q4 2020 · Feb 29 | 2020-02-29 | 1.2M | 0 | 0.00% |
| Q3 2020 | 2019-11-30 | 1.2M | 0 | 0.00% |
| Q2 2020 | 2019-08-31 | 1.2M | 0 | 0.00% |
| Q1 2020 | 2019-05-31 | 1.2M | −567 | −0.05% |
| Q4 2019 | 2019-02-28 | 1.2M | 0 | 0.00% |
| Q3 2019 | 2018-11-30 | 1.2M | 0 | 0.00% |
| Q2 2019 | 2018-08-31 | 1.2M | 0 | 0.00% |
| Q1 2019 | 2018-05-31 | 1.2M | 567 | +0.05% |
| Q4 2018 | 2018-02-28 | 1.2M | 0 | 0.00% |
| Q3 2018 | 2017-11-30 | 1.2M | −567 | −0.05% |
| Q2 2018 | 2017-08-31 | 1.2M | −567 | −0.05% |
| Q1 2018 | 2017-05-31 | 1.2M | −567 | −0.05% |
| Q4 2017 | 2017-02-28 | 1.2M | 2,389 | +0.20% |
| Q3 2017 | 2016-11-30 | 1.2M | 2,956 | +0.25% |
| Q2 2017 | 2016-08-31 | 1.2M | 2,956 | +0.25% |
| Q1 2017 | 2016-05-31 | 1.2M | 2,956 | +0.25% |
| Q4 2016 | 2016-02-29 | 1.2M | 0 | 0.00% |
| Q3 2016 | 2015-11-30 | 1.2M | 348 | +0.03% |
| Q2 2016 | 2015-08-31 | 1.2M | −2,956 | −0.25% |
| Q1 2016 | 2015-05-31 | 1.2M | −2,956 | −0.25% |
| Q4 2015 | 2015-02-28 | 1.2M | −2,956 | −0.25% |
| Q3 2015 | 2014-11-30 | 1.2M | −304 | −0.03% |
| Q2 2015 | 2014-08-31 | 1.2M | 0 | 0.00% |
| Q1 2015 | 2014-05-31 | 1.2M | 0 | 0.00% |
| Q4 2014 | 2014-02-28 | 1.2M | 0 | 0.00% |
| Q3 2014 | 2013-11-30 | 1.2M | −3,000 | −0.25% |
| Q2 2014 | 2013-08-31 | 1.2M | — | — |
| Q1 2014 | 2013-05-31 | 1.2M | — | — |
| Q4 2013 | 2013-02-28 | 1.2M | 3,304 | +0.28% |
| Q3 2013 | 2012-11-30 | 1.2M | — | — |
| Q4 2012 | 2012-02-29 | 1.2M | 0 | 0.00% |
| Q4 2011 | 2011-02-28 | 1.2M | — | — |
Yubo International Biotech shares outstanding trends
Over the last five fiscal years, Yubo International Biotech's shares outstanding moved from 118.2M to 170.4M, a change of 52.2M. The latest reported quarter, Q2 2026, shows 170.4M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when a stock-split conversion ratio is reported directly or evidenced by a later filing’s restated historical share balance. After repeated reverse splits, an old period can represent less than one current-basis share; this is a split-adjusted equivalent, not a literal historical certificate count. Values remain as reported when no reliable split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Yubo International Biotech source filings ↗